Rehabilitation Department Clinical Research
||Dr Angie Morrow
||9845 2132 / 31
See also: Rehabilitation in the Hospital's Directory of Services and Rehabilitation clinics in the Hospital's Directory of Bandaged Bear Clinics and Outpatient Services.
Summary of Unit
The Rehabilitation Department is actively involved in clinical research to further advance the area of paediatric rehabilitation. Approximately 60% of our staff are actively involved in clinical research. This research is considered to be an ongoing and important part of our day to day work. Clinical research means research that is conducted with real patients, as compared to laboratory and other types of research.
The research committee was established to assist staff with writing and planning clinical research questions. The committee compromises a chairperson, secretary and at least 3 other members of the department representative of therapists, physicians and neuropsychologists.
The role of the committee is to advise the investigator on the appropriateness, feasibility and suitability of proposed research projects to be completed in the department. Recommendations and approval must be obtained from this committee before the project is submitted to the Children's Hospital Ethics Committee for consideration.
For further information, please call Rehabilitation Department on (02) 9845 2132 and ask for a representative of the Rehabilitation research committee.
The Hospital's Research and Development Manager is Anne O'Neill on (02) 9845 1316.
Our current areas of research interest include:
- spasticity management using botulinum toxin, oral baclofen or intrathecal baclofen
- outcomes following acquired brain injury
- pharmacological and cognitive treatment options for children following acquired brain injury (e.g. attention difficulties, reading difficulties, visual processing difficulties).
- evaluation of interventions such as serial casting, exercise, or orthotics.
- natural history and outcomes after interventions for children and adolescents with cerebral palsy.
- dystonia management and treatment including deep brain stimulation.
We would like to invite students interested in being involved in research projects through our Department to contact us on (02) 9845 2132. This is open to allied health, nursing and medical.
Publications 2006 - 2008
Scheinberg A, O'Flaherty S, Waugh MC, Baxter A, Gurd K. Letter Botulinum neurotoxin a: an unusual systemic effect "43 (2007) 499-501" Journal of Paediatrics and Child Health 2008. Vol 44 pp 468-9
Mackey A, Miller F, Walt S, Waugh M, Stott N. Use of Three-Dimensional Kinematic Analysis Following Upper Limb Botulinum Toxin A for Children with Hemiplegia European Journal of Neurology 2008 15 1191-1198
Soo C, Tate R., Williams L, Waddingham S, & Waugh M.C. Development and validation of the Paediatric Care and Needs Scale for children and youth with acquired brain injury. 2008 Developmental Neurorehabilitation 11:3 204-214
Liu AJ, Briody JN, Munns CF, Waugh MCA. Regional changes In Bone Mineral Density following Spinal Cord Injury in Children. Developmental Neurorehabilitation 2008; 11(1):51-59
Hunter C, Spence K, Scheinberg A. Untangling the web of critical incidents: Ethnography in a paediatric setting. Anthropology and Medicine (Special issue: When it's a ward or a clinic: hospital ethnography). 2008;15(2):91-103
Hunter C, Scheinberg A, Harnett E, Spence K, Iedema R. Innovative approaches to researching patient safety. (Poster) International forum on quality and safety in health-care. Paris April 2008.
Alhusaini A, Crosbie J, Shepherd R, Dean C, Scheinberg A. Passive mechanical properties of the calf muscles in children with cerebral palsy compared to healthy children. Dev Med Child Neurol Supp 113;50:38 ( Abstract) AusACPDM Brisbane April 2008)
Hayden S, Scheinberg A, Ward A. Intrathecal Baclofen for children with spasticity and/or dystonia. Goal attainment and adverse events. Dev Med Child Neurol. 2008 Supp 113;50:6 (AusACPDM Brisbane April 2008).
Forrestor M, Mihrshahi S, Waugh MC, O'Flaherty, Rice J, Graham HK, Scheinberg A. Conscious sedation and general anaesthetic for intramuscular Botulinum toxin-A injections for spasticity management - a two centre cross sectional prospective audit. Dev Med Child Neurol. 2008 Supp 113;50:5 (AusACPDM Conference Brisbane April 2008)
Hunter C, Scheinberg A, Spence K, Harnett L. Space for improvements: an interesting journey (Poster). National Initiative for Children's Healthcare Quality 7th Annual Forum. Florida March 2008.
Waugh MC, Evans R, Aroyan K. Video workshop on upper limb assessment and treatment for clinical practice. Abstract/Workshop. Developmental Medicine and Child Neurology. Supplement 113 April 2008 Vol 50 pp28
Waugh MC, Noronha J, Gibson W, Murphy P. Transition from paediatric to adult brain injury services: a survey of the family's experience. (Poster). Developmental Medicine and Child Neurology. Supplement 113 April 2008 Vol 50 pp56
Field B, Scheinberg A. Westmead Hospital Clinic for Adults with Physical Disabilities (Poster). IASSID 13th World Congress. People with Intellectual Disabilities: Citizens of the World, Capetown South Africa August 2008.
Stewart, K, Aroyan, K, Hayden, S, Scheinberg, A. (Poster). The therapist's role in Intrathecal Baclofen Therapy. The Australian Occupational Therapy Conference, Melbourne Sept 2008.
Hayden, S., Scheinberg, A., Ward, A. Intrathecal Baclofen for children with spasticity and/or dystonia: Goal attainment and adverse events. American Academy of Cerebral Palsy and Developmental Medicine. (Poster) Miami September 2008.
Wallen M, O'Flaherty S, Waugh M-C. Functional outcomes of intramuscular botulinum toxin type A and occupational therapy in the upper limbs of children with cerebral palsy: a Randomized Controlled Trial . Arch Phys Med Rehabil 2007; 88(1):1-10
Brunsdon, R., Nickels, L., Coltheart, M. (2007) Topographical Disorientation: Towards an Integrated Framework for Assessment. Neuropsychological Rehabilitation, 17 (1), 34-52
Brunsdon, R., Nickels, L., Coltheart, M., & Joy, P. (2007). Assessment and treatment of childhood topographical disorientation: A case study. Neuropsychological Rehabilitation, 17 (1), 53-94
Scheinberg, A, Hall, K, Lam, L, O'Flaherty, S. Oral baclofen in children with cerebral palsy: A double-blind cross-over pilot study. Journal of paediatrics and child health. 2006; 42:715-20
Lannin, N, Scheinberg, A, Clark, K. AACPDM systematic review of the effectiveness of therapy for children with cerebral palsy after botulinum toxin A injections. Developmental medicine and child neurology. 2006; 48:533-9
Banerjee KJ, Glasson C, O'Flaherty SJ. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy. Developmental Medicine & Child Neurology. 2006; 48,11, 883-7
Brunsdon, R., Coltheart, M., Nickels, L., & Joy, P. (2006) Developmental prosopagnosia: A case analysis and treatment study. Cognitive Neuropsychology, 23 (6), 822-840
Brunsdon, R., Coltheart, M., & Nickels, L (2006). Severe developmental letter processing impairment: A treatment case study. Cognitive Neuropsychology, 23 (6), 795-821
Muenchberger, H., Assaad, N., Joy, P., Brunsdon, R., & Shores, A (2006). Idiopathic Macrocephaly in the Infant: Longterm neurological and neuropsychological outcome. Childs Nervous System, 22(10), 1242-8
Kohnen, S., Nickels, L., Coltheart, M., & Brunsdon, R. (2006). Predicting generalisation in the training of irregular word spelling: Treating lexical spelling deficits in a child with mixed dysgraphia. Australian Journal of Psychology, 58(Suppl. 1), 81.
This document was reviewed on Monday, 7 September 2009